PROTID builds further on previous research into the interaction of DM and TB by the TANDEM project. Publications from the TANDEM project can be found here.

PROTID publications of main research findings are Open Access in order to make results easily accessible for low- to middle-income countries. This is in compliance with H2020 and EDCTP policies.


A comment in the Lancet Respiratory Medicine. Shorter regimens for tuberculosis preventive treatment: piecing together the global implementation jigsaw
Reinout van Crevel, Philip C Hill,

Response to IJTLD article ‘‘Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis”

Van Crevel, Reinout & Andia-Biraro, I & Ntinginya, N & Chamba, Nyasatu & Critchley, Julia & te Brake, Lindsey & Kibirige, D & Manyama, C & Kilonzo, K & Pennington, M & Sharples, K & Hill, P. (2020). IJTLD 2020 – letter PROTID. 10.5588/ijtld.20.0033.

The Interaction of Diabetes and Tuberculosis: Translating Research to Policy and Practice

Van Crevel, Reinout &  Critchley, Julia A. (2021). Tropical Medicine Infectious Disease 2021, 6, 8.

Tuberculosis preventive therapy for people with diabetes mellitus

Olomi, W., Andia Biraro, I., Kilonzo, K., te Brake, L.,  Kibirige, D., Chamba, N., Elias Ntinginya, N., Sabi, I., Critchley, J., Sharples, K., Hill, P.C., van Crevel, R., PROTID Consortium (2021). Clinical Infectious Diseases, ciab755,